ALLTEST Xylazine Tests
(25 Tests)
A rapid test for the qualitative detection of xylazine in human urine or powder.
For forensic use only. Not for in vitro dianostic use.
The Xylazine (XYL) Rapid Test Panel (Urine & Powder) is a rapid chromatographic immunoassay for the detection of xylazine in human urine or powder at a cut-off concentration of 1,000 ng/mL.
This assay provides only a qualitative, preliminary test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography/Mass Spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Features and Benefits
- Easy Visual Interpretation
- Convenient Procedure
- High Accuracy
- Fast Results in 5 Minute
- Sensitivity >99.9% , Specificity >99.9% , Accuracy >99.9%
- Consistent Quality.
- Competitive Price.
The Xylazine Rapid Test Panel (Urine) is a rapid chromatographic immunoassay for the detection of x ylazine in human urine at a cut off concentration of 1 000 ng/mL. This test will detect other related compounds, please refer to the Analytical Specificity table in this package insert. This assay provides only a qualitative, preliminary test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography/ Mass Spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Xylazine is a veterinary tranquilizer, which is not approved for human use in the United States, but is commonly used for sedating large animals. Although human intoxication with xylazine has been reported sporadically over the past several decades in a number of case studies. It was also noted in the literature describing drug overdose deaths in Philadelphia as early as 2006, yet it did not appear in high prevalence at that time. However, since the mid-2010 s, xylazine has been noticed by people who inject drugs (PWID) and public health practitioners as an increasingly commonplace additive in the street opioid supply of Philadelphia. Further, recent reports from Connecticut implicated xylazine in a rising fraction of overdose deaths in 2019–2020.
The Xylazine Rapid Test Panel (Urine) is a rapid urine-screening test that can be performed without the use of an instrument. The test utilizes the antibody to selectively detect elevated levels of xylazine in urine. The Xylazine Rapid Test Panel (Urine) yields a positive result when the xylazine in urine exceed 1,000ng/mL.
